{ "api_version": "1", "request": { "url": "https://clinicaltrialsfind.com/api/v1/search.json?intervention=Topical+Corticosteroid&page=2", "query": { "intervention": "Topical Corticosteroid", "page": 2 }, "page_size": 10 }, "pagination": { "page": 2, "page_size": 10, "total_count": 10, "total_pages": 1, "next_page_url": null, "previous_page_url": "https://clinicaltrialsfind.com/api/v1/search.json?intervention=Topical+Corticosteroid&page=1&page_size=10" }, "source": "remote", "last_synced_at": "2026-09-26T03:45:17.864Z", "attribution": "Data derived from public ClinicalTrials.gov records. The official record at https://clinicaltrials.gov/ remains the source of truth for current availability, contacts, and full study details.", "notes": [ "This endpoint exposes only public summary fields — no participant contact emails, phone numbers, or scraped investigator contact details.", "For contact information and full protocol detail, follow each trial's `official_url` to the ClinicalTrials.gov record.", "This API is a navigational aid. It does not provide medical advice, eligibility determinations, or compensation guarantees." ], "trials": [ { "nct_id": "NCT05436535", "title": "Longitudinal Endotyping Of Atopic Dermatitis Through Transcriptomic Skin Analysis", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE4" ], "conditions": [ "Atopic Dermatitis" ], "interventions": [ { "name": "Dupilumab", "type": "BIOLOGICAL" }, { "name": "Vanicream- Dupilumab-naïve", "type": "DRUG" }, { "name": "Triamcinolone Acetonide", "type": "DRUG" }, { "name": "Hydrocortisone", "type": "DRUG" }, { "name": "Vanicream- Active", "type": "DRUG" }, { "name": "Vanicream- Experienced Dupilumab", "type": "DRUG" } ], "intervention_types": [ "BIOLOGICAL", "DRUG" ], "sponsor": "National Institute of Allergy and Infectious Diseases (NIAID)", "sponsor_class": "NIH", "healthy_volunteers": true, "eligibility": { "minimum_age": "6 Years", "maximum_age": null, "sex": "ALL", "summary": "6 Years and older" }, "enrollment_count": 433, "start_date": "2022-11-21", "completion_date": "2025-10-24", "has_results": true, "last_update_posted_date": "2026-06-04", "last_synced_at": "2026-09-26T03:45:17.864Z", "location_count": 10, "location_summary": "La Jolla, California • Los Angeles, California • Denver, Colorado + 7 more", "locations": [ { "city": "La Jolla", "state": "California" }, { "city": "Los Angeles", "state": "California" }, { "city": "Denver", "state": "Colorado" }, { "city": "Boston", "state": "Massachusetts" }, { "city": "New York", "state": "New York" } ], "official_url": "https://clinicaltrials.gov/study/NCT05436535" }, { "nct_id": "NCT04097730", "title": "Steroids and Cross-linking for Ulcer Treatment", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "Keratitis Bacterial" ], "interventions": [ { "name": "Moxifloxacin Ophthalmic", "type": "DRUG" }, { "name": "Difluprednate Ophthalmic", "type": "DRUG" }, { "name": "Riboflavin Ophthalmic", "type": "DRUG" }, { "name": "Topical Placebo", "type": "OTHER" } ], "intervention_types": [ "DRUG", "OTHER" ], "sponsor": "Thomas M. Lietman", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 280, "start_date": "2020-09-24", "completion_date": "2024-09-18", "has_results": false, "last_update_posted_date": "2025-02-03", "last_synced_at": "2026-09-26T03:45:17.864Z", "location_count": 2, "location_summary": "San Francisco, California • Miami, Florida", "locations": [ { "city": "San Francisco", "state": "California" }, { "city": "Miami", "state": "Florida" } ], "official_url": "https://clinicaltrials.gov/study/NCT04097730" }, { "nct_id": "NCT04008784", "title": "Improvement of Short Term Outcome of Mild to Moderate Atopic Dermatitis Using a Combination of Crisaborole and a Concomitant Topical Corticosteroid Over a 8 Week Period", "overall_status": "COMPLETED", "study_type": "OBSERVATIONAL", "phases": [], "conditions": [ "Atopic Dermatitis" ], "interventions": [ { "name": "Crisaborole 2% Topical Application Ointment [EUCRISA]", "type": "DRUG" }, { "name": "Triamcinolone Acetonide 0.1% Ointment", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Clinical Research Center of the Carolinas", "sponsor_class": "OTHER", "healthy_volunteers": true, "eligibility": { "minimum_age": "2 Years", "maximum_age": "79 Years", "sex": "ALL", "summary": "2 Years to 79 Years" }, "enrollment_count": 16, "start_date": "2019-09-16", "completion_date": "2020-09-08", "has_results": false, "last_update_posted_date": "2021-04-28", "last_synced_at": "2026-09-26T03:45:17.864Z", "location_count": 1, "location_summary": "Charleston, South Carolina", "locations": [ { "city": "Charleston", "state": "South Carolina" } ], "official_url": "https://clinicaltrials.gov/study/NCT04008784" }, { "nct_id": "NCT01018134", "title": "Desoximetasone Spray 0.05%, 0.25%; Dose Ranging Study", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "Psoriasis" ], "interventions": [ { "name": "Desoximetasone 0.05% once daily", "type": "DRUG" }, { "name": "Desoximetasone 0.05% twice daily", "type": "DRUG" }, { "name": "Desoximetasone 0.25% once daily", "type": "DRUG" }, { "name": "Vehicle once daily", "type": "DRUG" }, { "name": "Vehicle twice daily", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Sun Pharmaceutical Industries, Inc.", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 151, "start_date": "2009-11", "completion_date": "2010-05", "has_results": true, "last_update_posted_date": "2014-08-05", "last_synced_at": "2026-09-26T03:45:17.864Z", "location_count": 7, "location_summary": "Miami, Florida • Martinez, Georgia • Olathe, Kansas + 4 more", "locations": [ { "city": "Miami", "state": "Florida" }, { "city": "Martinez", "state": "Georgia" }, { "city": "Olathe", "state": "Kansas" }, { "city": "Wichita", "state": "Kansas" }, { "city": "Albuquerque", "state": "New Mexico" } ], "official_url": "https://clinicaltrials.gov/study/NCT01018134" }, { "nct_id": "NCT05505214", "title": "Topical Steroids & Bacterial Decolonization for Radiation Dermatitis", "overall_status": "WITHDRAWN", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "Radiation Dermatitis" ], "interventions": [ { "name": "Bacterial decolonization", "type": "DRUG" }, { "name": "Mometasone furoate 0.1% cream", "type": "DRUG" }, { "name": "Bacterial decolonization and Mometasone furoate 0.1% cream", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Montefiore Medical Center", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 0, "start_date": "2023-09-01", "completion_date": "2025-09-01", "has_results": false, "last_update_posted_date": "2023-12-22", "last_synced_at": "2026-09-26T03:45:17.864Z", "location_count": 1, "location_summary": "The Bronx, New York", "locations": [ { "city": "The Bronx", "state": "New York" } ], "official_url": "https://clinicaltrials.gov/study/NCT05505214" }, { "nct_id": "NCT01846442", "title": "Topical DHEA Against Vaginal Atrophy", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "Vaginal Atrophy" ], "interventions": [ { "name": "Placebo", "type": "DRUG" }, { "name": "DHEA (0.25%)", "type": "DRUG" }, { "name": "DHEA (0.5%)", "type": "DRUG" }, { "name": "DHEA (1.0%)", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "EndoCeutics Inc.", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "40 Years", "maximum_age": "75 Years", "sex": "FEMALE", "summary": "40 Years to 75 Years · Female only" }, "enrollment_count": 218, "start_date": "2007-06", "completion_date": "2008-10", "has_results": true, "last_update_posted_date": "2017-08-29", "last_synced_at": "2026-09-26T03:45:17.864Z", "location_count": 2, "location_summary": "Cleveland, Ohio • Norfolk, Virginia", "locations": [ { "city": "Cleveland", "state": "Ohio" }, { "city": "Norfolk", "state": "Virginia" } ], "official_url": "https://clinicaltrials.gov/study/NCT01846442" }, { "nct_id": "NCT06865170", "title": "Pain Perception During Intra-Articular Knee Joint Injection: What is the Effect of Needle Gauge and the Use of Ethyl Chloride?", "overall_status": "NOT_YET_RECRUITING", "study_type": "INTERVENTIONAL", "phases": [ "PHASE4" ], "conditions": [ "Osteoarthritis (OA) of the Knee", "Fear of Needles" ], "interventions": [ { "name": "25 gauge needle", "type": "PROCEDURE" }, { "name": "22 gauge needle", "type": "PROCEDURE" }, { "name": "+/- Ethyl Chloride Topical Aerosol Anesthetic", "type": "PROCEDURE" } ], "intervention_types": [ "PROCEDURE" ], "sponsor": "University of California, Davis", "sponsor_class": "OTHER", "healthy_volunteers": true, "eligibility": { "minimum_age": "40 Years", "maximum_age": "89 Years", "sex": "ALL", "summary": "40 Years to 89 Years" }, "enrollment_count": 88, "start_date": "2026-12", "completion_date": "2026-12", "has_results": false, "last_update_posted_date": "2026-09-16", "last_synced_at": "2026-09-26T03:45:17.864Z", "location_count": 1, "location_summary": "Sacramento, California", "locations": [ { "city": "Sacramento", "state": "California" } ], "official_url": "https://clinicaltrials.gov/study/NCT06865170" }, { "nct_id": "NCT00990561", "title": "Comparing the Efficacy of Ultravate Ointment in Combination With Lac-Hydrin Lotion in the Treatment of Psoriasis", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE4" ], "conditions": [ "Stable Plaque Psoriasis" ], "interventions": [ { "name": "Ultravate ointment twice daily + LacHydrin lotion twice daily", "type": "DRUG" }, { "name": "Ultravate ointment once daily + LacHydrin lotion twice daily", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "University of California, San Francisco", "sponsor_class": "OTHER", "healthy_volunteers": true, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 40, "start_date": "2009-07", "completion_date": "2010-06", "has_results": true, "last_update_posted_date": "2019-01-04", "last_synced_at": "2026-09-26T03:45:17.864Z", "location_count": 1, "location_summary": "San Francisco, California", "locations": [ { "city": "San Francisco", "state": "California" } ], "official_url": "https://clinicaltrials.gov/study/NCT00990561" }, { "nct_id": "NCT03229551", "title": "Xylitol for Chronic Sinusitis", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2", "PHASE3" ], "conditions": [ "Chronic Rhinosinusitis", "Rhinosinusitis", "Sinusitis", "Drain Sinus", "Endoscopic Sinus Surgery", "Biofilms", "Bacterial Overgrowth" ], "interventions": [ { "name": "Xylitol", "type": "DRUG" }, { "name": "Saline", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Ochsner Health System", "sponsor_class": "OTHER", "healthy_volunteers": true, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 1, "start_date": "2018-03-01", "completion_date": "2018-07-16", "has_results": false, "last_update_posted_date": "2023-04-07", "last_synced_at": "2026-09-26T03:45:17.864Z", "location_count": 1, "location_summary": "New Orleans, Louisiana", "locations": [ { "city": "New Orleans", "state": "Louisiana" } ], "official_url": "https://clinicaltrials.gov/study/NCT03229551" }, { "nct_id": "NCT05953090", "title": "VALOR: Vaginal Atrophy & Long-term Observation of Recovery", "overall_status": "RECRUITING", "study_type": "INTERVENTIONAL", "phases": [ "NA" ], "conditions": [ "Atrophic Vaginitis", "Vaginal Atrophy", "Genitourinary Syndrome of Menopause", "Lichen Sclerosus of Vulva", "Lichen Planus of Vulva", "Lichen Simplex of Vulva (Disorder)" ], "interventions": [ { "name": "7-0940", "type": "DEVICE" } ], "intervention_types": [ "DEVICE" ], "sponsor": "Stratpharma AG", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "FEMALE", "summary": "18 Years and older · Female only" }, "enrollment_count": 2000, "start_date": "2023-10-30", "completion_date": "2028-12", "has_results": false, "last_update_posted_date": "2026-02-20", "last_synced_at": "2026-09-26T03:45:17.864Z", "location_count": 14, "location_summary": "Birmingham, Alabama • Burbank, California • Laguna Hills, California + 11 more", "locations": [ { "city": "Birmingham", "state": "Alabama" }, { "city": "Burbank", "state": "California" }, { "city": "Laguna Hills", "state": "California" }, { "city": "Los Alamitos", "state": "California" }, { "city": "Newport Beach", "state": "California" } ], "official_url": "https://clinicaltrials.gov/study/NCT05953090" } ] }